HCPCS Code M1484

Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)

Medical services

M1484 is a valid 2026 HCPCS code for Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis) or just “No rpt hcv rna perf med rsn” for short, used in Medical care.

HCPCS Code Details - M1484

HCPCS Level II Code
Medical services
HCPCS Code M1484
Description

Long description:
Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)

Short description:
No rpt hcv rna perf med rsn

HCPCS Modifier1
HCPCS Pricing indicator 00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
Multiple pricing indicator 9 - Not applicable as HCPCS not priced separately by part B or value is not established
Coverage code C - Carrier judgment
BETOS2 code Z2 - Undefined codes
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2026
Date added Added Jan 01, 2026
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment

See also

  • HCPCS M1483 · Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period

  • HCPCS G9563 · Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

  • HCPCS G9645 · Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

  • HCPCS G9807 · Patients who did not receive cervical cytology or an hpv test

  • HCPCS M1252 · Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit

  • HCPCS M1318 · Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp

  • HCPCS M1341 · Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period

  • HCPCS M1344 · Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score

  • HCPCS M1346 · Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period

  • HCPCS M1349 · Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period

  • HCPCS M1353 · Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

  • HCPCS M1354 · Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

  • HCPCS M1358 · Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

  • HCPCS M1363 · Patients who did not have a follow-up assessment within 120 days of the index assessment

  • HCPCS M1410 · Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis

  • HCPCS M1415 · Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy

  • HCPCS M1485 · Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”